The social distribution of psychological distress and depression in older adults.
John Cairney, Neal Krause
https://pubmed.ncbi.nlm.nih.gov/16377773/Actively Recruiting
Led by Göteborg University · Updated on 2025-02-28
140
Participants Needed
7
Research Sites
52 weeks
Total Duration
Older adults aged 75 and above often experience symptoms of depression and anxiety, alongside challenges such as pain, grief, loneliness, cognitive decline, and reduced daily functioning. These issues can lead to psychological distress, which is common in this age group but often goes untreated in primary care. This trial aims to evaluate an existential psychological group treatment designed specifically for older adults facing psychological distress, comparing it to supportive telephone calls within a primary care setting using a randomized controlled design. Participants will be randomly assigned to one of two groups the experimental group will attend seven weekly existential group therapy sessions, each lasting 90 to 120 minutes, focusing on aging-related existential themes like loneliness and fear of death. The control group will receive brief supportive telephone calls once a week for seven weeks. Both groups will be evaluated at similar time points to compare effects and monitor any side effects. Therapists receive special training and sessions are recorded to ensure treatment fidelity. During the study, participants will complete assessments before, during, immediately after treatment, and at a three-month follow-up. These include measures of psychological distress, experiential avoidance, anxiety, depression, zest for life, sleep problems, and quality of life. Screening involves questionnaires and interviews to confirm eligibility. The study also includes focus group interviews to explore participants experiences. The total involvement covers the treatment period and follow-up assessments to understand the treatments impact over time.
CONDITIONS
Existential Group Treatment for Older Adults (75+) With Psychological Distress in Primary Care
I
Isak Erling, Psy M
M
Margda Waern, Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Göteborg University
Lead Sponsor
Vastra Gotaland Region
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Screening can take place at the primary care center or at home, depending on participant preference.
Duration - 7 weeks
Participants receive either existential group therapy in weekly group sessions or supportive telephone calls once a week.
Weekly visits for 7 weeks (group sessions or telephone calls)
Duration - 3 months after treatment
Participants complete evaluations immediately after the intervention and at a 3-month follow-up to assess changes in psychological distress and other outcomes.
2 follow-up assessments (immediately post-treatment and 3 months later)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
John Cairney, Neal Krause
https://pubmed.ncbi.nlm.nih.gov/16377773/Jojanneke Korte, Ernst T Bohlmeijer, Filip Smit
https://pubmed.ncbi.nlm.nih.gov/19619284/Therese Rydberg Sterner, Synneve Dahlin-Ivanoff, Pia Gudmundsson...
https://pubmed.ncbi.nlm.nih.gov/33287708/Liesl M Heinrich, Eleonora Gullone
https://pubmed.ncbi.nlm.nih.gov/16952717/Joël Vos, Meghan Craig, Mick Cooper
https://pubmed.ncbi.nlm.nih.gov/25045907/M F Folstein, L N Robins, J E Helzer
https://pubmed.ncbi.nlm.nih.gov/6860082/Kimberly A Van Orden, Stefan Wiktorsson, Paul Duberstein...
https://pubmed.ncbi.nlm.nih.gov/25158916/Daniel Spitzenstätter, Tatjana Schnell
https://pubmed.ncbi.nlm.nih.gov/33357041/D V Sheehan, Y Lecrubier, K H Sheehan...
https://pubmed.ncbi.nlm.nih.gov/9881538/Lisa Iverach, Ross G Menzies, Rachel E Menzies
https://pubmed.ncbi.nlm.nih.gov/25306232/Göteborg University
Lead Sponsor
Vastra Gotaland Region
Collaborating Sponsor